SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-006916
Filing Date
2022-02-11
Accepted
2022-02-11 14:23:15
Documents
13
Period of Report
2022-02-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea155463-8k_immucell.htm   iXBRL 8-K 25996
2 INDEPENDENT CONTRACTOR AGREEMENT BETWEEN THE COMPANY AND JOSEPH H. CRABB DATED A ea155463ex99-1_immucell.htm EX-99.1 40236
  Complete submission text file 0001213900-22-006916.txt   248895

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE iccc-20220211.xsd EX-101.SCH 3033
4 XBRL LABEL FILE iccc-20220211_lab.xml EX-101.LAB 34476
5 XBRL PRESENTATION FILE iccc-20220211_pre.xml EX-101.PRE 22595
7 EXTRACTED XBRL INSTANCE DOCUMENT ea155463-8k_immucell_htm.xml XML 3484
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

IRS No.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12934 | Film No.: 22619405
SIC: 2835 In Vitro & In Vivo Diagnostic Substances